

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.53422598 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.30602841 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.30602841 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.06429726 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.90388092 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.83122604 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.73175205 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.48252427 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.48252427 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.48252427 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.48252427 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.48252427 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.48252427 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.28463553 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.26361083 |
| 16 | detection of other organism (GO:0098543) | 4.23216505 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 4.17670804 |
| 18 | detection of bacterium (GO:0016045) | 4.16484342 |
| 19 | leukocyte aggregation (GO:0070486) | 4.01299596 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.96750595 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 3.89886153 |
| 22 | B cell receptor signaling pathway (GO:0050853) | 3.88622344 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 3.85693089 |
| 24 | response to peptidoglycan (GO:0032494) | 3.80951675 |
| 25 | germinal center formation (GO:0002467) | 3.79096636 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 3.76824982 |
| 27 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.71581048 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.70530998 |
| 29 | NIK/NF-kappaB signaling (GO:0038061) | 3.63495047 |
| 30 | positive thymic T cell selection (GO:0045059) | 3.56120444 |
| 31 | cellular response to type I interferon (GO:0071357) | 3.55899494 |
| 32 | type I interferon signaling pathway (GO:0060337) | 3.55899494 |
| 33 | detection of external biotic stimulus (GO:0098581) | 3.55844498 |
| 34 | response to type I interferon (GO:0034340) | 3.54713124 |
| 35 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.47118031 |
| 36 | response to muramyl dipeptide (GO:0032495) | 3.42029972 |
| 37 | cellular extravasation (GO:0045123) | 3.41601078 |
| 38 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.36831891 |
| 39 | response to interleukin-15 (GO:0070672) | 3.36644719 |
| 40 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.35997517 |
| 41 | regulation of antigen processing and presentation (GO:0002577) | 3.33468112 |
| 42 | negative thymic T cell selection (GO:0045060) | 3.30719300 |
| 43 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.28911558 |
| 44 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.28100381 |
| 45 | regulation of T cell tolerance induction (GO:0002664) | 3.26176948 |
| 46 | detection of molecule of bacterial origin (GO:0032490) | 3.23948366 |
| 47 | tolerance induction (GO:0002507) | 3.20730700 |
| 48 | thymic T cell selection (GO:0045061) | 3.19837244 |
| 49 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.17745013 |
| 50 | negative T cell selection (GO:0043383) | 3.17344469 |
| 51 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.16404240 |
| 52 | negative regulation of T cell mediated immunity (GO:0002710) | 3.15012610 |
| 53 | positive regulation of B cell differentiation (GO:0045579) | 3.13150971 |
| 54 | * defense response to protozoan (GO:0042832) | 3.13145700 |
| 55 | regulation of B cell differentiation (GO:0045577) | 3.13010552 |
| 56 | T cell selection (GO:0045058) | 3.12872760 |
| 57 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11515734 |
| 58 | detection of biotic stimulus (GO:0009595) | 3.11104872 |
| 59 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09301991 |
| 60 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.05533469 |
| 61 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.03327851 |
| 62 | regulation of tolerance induction (GO:0002643) | 3.00150284 |
| 63 | cellular response to interleukin-15 (GO:0071350) | 2.97058089 |
| 64 | response to host immune response (GO:0052572) | 2.95199350 |
| 65 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.95199350 |
| 66 | positive T cell selection (GO:0043368) | 2.94066451 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 2.93984901 |
| 68 | B cell mediated immunity (GO:0019724) | 2.93273588 |
| 69 | neutrophil activation (GO:0042119) | 2.92021920 |
| 70 | * response to protozoan (GO:0001562) | 2.90679523 |
| 71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.88286704 |
| 72 | T cell migration (GO:0072678) | 2.87806885 |
| 73 | regulation of mast cell degranulation (GO:0043304) | 2.87794771 |
| 74 | myeloid dendritic cell differentiation (GO:0043011) | 2.87585332 |
| 75 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.85999037 |
| 76 | response to host (GO:0075136) | 2.85999037 |
| 77 | response to host defenses (GO:0052200) | 2.85999037 |
| 78 | granulocyte activation (GO:0036230) | 2.85530451 |
| 79 | respiratory burst (GO:0045730) | 2.85155413 |
| 80 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.84280075 |
| 81 | macrophage activation (GO:0042116) | 2.84041586 |
| 82 | positive regulation of antigen processing and presentation (GO:0002579) | 2.81604517 |
| 83 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.79037911 |
| 84 | negative regulation of innate immune response (GO:0045824) | 2.74323052 |
| 85 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.73340655 |
| 86 | positive regulation of interferon-alpha production (GO:0032727) | 2.72232212 |
| 87 | myeloid dendritic cell activation (GO:0001773) | 2.71978625 |
| 88 | regulation of interferon-alpha production (GO:0032647) | 2.69491945 |
| 89 | regulation of leukocyte degranulation (GO:0043300) | 2.69157532 |
| 90 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.68829600 |
| 91 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.68829600 |
| 92 | positive regulation of tolerance induction (GO:0002645) | 2.68275862 |
| 93 | negative regulation of interleukin-6 production (GO:0032715) | 2.66130185 |
| 94 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.65212749 |
| 95 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.64830273 |
| 96 | T-helper 1 type immune response (GO:0042088) | 2.63341307 |
| 97 | B cell homeostasis (GO:0001782) | 2.62000155 |
| 98 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.60098265 |
| 99 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.59227234 |
| 100 | negative regulation of type 2 immune response (GO:0002829) | 2.58890075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.03372138 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.73165458 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.71446494 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.60831563 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.20328720 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.96270151 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.89550719 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.78002698 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.72311976 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.64533520 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.64191033 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62583161 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.54650189 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.45023212 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42048629 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.39868516 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.39565004 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.35555550 |
| 19 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.34073374 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.33343268 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.33319020 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.31856432 |
| 23 | * MAF_26560356_Chip-Seq_TH1_Human | 2.25797117 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.21764420 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.16322903 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15706456 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.13950499 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.10969556 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.09937283 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05294816 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02039628 |
| 32 | * MYB_26560356_Chip-Seq_TH2_Human | 2.01555809 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 2.00237018 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.97187037 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96790710 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95675203 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.94505604 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94472537 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.92173030 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.91030225 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.89496327 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.88576519 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.86038732 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77937537 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.69917027 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.69774223 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.69305345 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68873075 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52589774 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51181299 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50323307 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39523706 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39413917 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37356688 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29807503 |
| 56 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29675767 |
| 57 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29112948 |
| 58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28103018 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27670386 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24700136 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24675210 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23890986 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20502034 |
| 64 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20465280 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20234297 |
| 66 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19312877 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19104578 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19078016 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16350311 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15922859 |
| 71 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.15774958 |
| 72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14239345 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14140657 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12646092 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05340182 |
| 76 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05145959 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05037332 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04770846 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03450782 |
| 80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03018399 |
| 81 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02074391 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01139364 |
| 83 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00950969 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00376178 |
| 85 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.00042936 |
| 86 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99813670 |
| 87 | KDM2B_26808549_Chip-Seq_K562_Human | 0.98027205 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97108832 |
| 89 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95507338 |
| 90 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.95474675 |
| 91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94989509 |
| 92 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.93874220 |
| 93 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.91972441 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91848857 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91504787 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89215357 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88383045 |
| 98 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.87904022 |
| 99 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85964727 |
| 100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84393109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.00280479 |
| 2 | MP0003436_decreased_susceptibility_to | 3.80626065 |
| 3 | MP0003724_increased_susceptibility_to | 3.63084031 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.48577196 |
| 5 | MP0001790_abnormal_immune_system | 3.13469583 |
| 6 | MP0005387_immune_system_phenotype | 3.13469583 |
| 7 | MP0001800_abnormal_humoral_immune | 2.92565399 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.81394230 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.80290756 |
| 10 | MP0000685_abnormal_immune_system | 2.79728059 |
| 11 | MP0005671_abnormal_response_to | 2.76045050 |
| 12 | MP0009785_altered_susceptibility_to | 2.69962348 |
| 13 | MP0002419_abnormal_innate_immunity | 2.63597631 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.62553743 |
| 15 | MP0005025_abnormal_response_to | 2.60367129 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.49979813 |
| 17 | MP0002723_abnormal_immune_serum | 2.48108645 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.33844339 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.31288437 |
| 20 | MP0001819_abnormal_immune_cell | 2.31204750 |
| 21 | MP0006082_CNS_inflammation | 2.30720677 |
| 22 | MP0004947_skin_inflammation | 2.14102683 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.02853626 |
| 24 | MP0004510_myositis | 2.01875565 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.99941564 |
| 26 | MP0002405_respiratory_system_inflammati | 1.99456043 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.99265599 |
| 28 | MP0005451_abnormal_body_composition | 1.86973634 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.82060709 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.80819741 |
| 31 | MP0000716_abnormal_immune_system | 1.80740573 |
| 32 | MP0002398_abnormal_bone_marrow | 1.80376625 |
| 33 | MP0001873_stomach_inflammation | 1.72959977 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.71914182 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.71084124 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.67381760 |
| 37 | MP0008260_abnormal_autophagy | 1.63390526 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.60820855 |
| 39 | MP0005310_abnormal_salivary_gland | 1.53409985 |
| 40 | MP0009840_abnormal_foam_cell | 1.53085332 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.52323304 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.49396636 |
| 43 | MP0009278_abnormal_bone_marrow | 1.45902645 |
| 44 | MP0000858_altered_metastatic_potential | 1.45645933 |
| 45 | MP0002722_abnormal_immune_system | 1.44846746 |
| 46 | MP0002429_abnormal_blood_cell | 1.41996258 |
| 47 | MP0008469_abnormal_protein_level | 1.38845852 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.38757276 |
| 49 | MP0003866_abnormal_defecation | 1.36841058 |
| 50 | MP0001853_heart_inflammation | 1.35295866 |
| 51 | MP0003828_pulmonary_edema | 1.31907657 |
| 52 | MP0009764_decreased_sensitivity_to | 1.31886007 |
| 53 | MP0003091_abnormal_cell_migration | 1.29153214 |
| 54 | MP0002933_joint_inflammation | 1.27854715 |
| 55 | MP0001851_eye_inflammation | 1.27300740 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.25643461 |
| 57 | MP0008004_abnormal_stomach_pH | 1.24978746 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.24923977 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.21863220 |
| 60 | MP0004381_abnormal_hair_follicle | 1.21654452 |
| 61 | MP0003075_altered_response_to | 1.17675214 |
| 62 | MP0005166_decreased_susceptibility_to | 1.14624004 |
| 63 | MP0003566_abnormal_cell_adhesion | 1.12236868 |
| 64 | MP0002396_abnormal_hematopoietic_system | 1.11728363 |
| 65 | MP0002254_reproductive_system_inflammat | 1.11630110 |
| 66 | MP0003448_altered_tumor_morphology | 1.10182819 |
| 67 | MP0004883_abnormal_blood_vessel | 1.09335312 |
| 68 | MP0001545_abnormal_hematopoietic_system | 1.07613451 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 1.07613451 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 1.05053009 |
| 71 | MP0005164_abnormal_response_to | 1.02093909 |
| 72 | MP0002132_abnormal_respiratory_system | 1.00685589 |
| 73 | MP0001663_abnormal_digestive_system | 0.98069131 |
| 74 | MP0000604_amyloidosis | 0.96971031 |
| 75 | MP0002166_altered_tumor_susceptibility | 0.94497469 |
| 76 | MP0000343_altered_response_to | 0.93751234 |
| 77 | MP0005390_skeleton_phenotype | 0.90104580 |
| 78 | MP0005023_abnormal_wound_healing | 0.90001461 |
| 79 | MP0003279_aneurysm | 0.87743216 |
| 80 | MP0003045_fibrosis | 0.87723824 |
| 81 | MP0000249_abnormal_blood_vessel | 0.87723561 |
| 82 | MP0005076_abnormal_cell_differentiation | 0.85444158 |
| 83 | MP0000490_abnormal_crypts_of | 0.82342597 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 0.80745361 |
| 85 | MP0009763_increased_sensitivity_to | 0.77763591 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 0.74886000 |
| 87 | MP0003690_abnormal_glial_cell | 0.73369045 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.71165086 |
| 89 | MP0003795_abnormal_bone_structure | 0.67879142 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.67392164 |
| 91 | MP0001849_ear_inflammation | 0.67286558 |
| 92 | MP0001958_emphysema | 0.66432452 |
| 93 | MP0002006_tumorigenesis | 0.65381641 |
| 94 | MP0008874_decreased_physiological_sensi | 0.64940997 |
| 95 | MP0005381_digestive/alimentary_phenotyp | 0.63361229 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 0.60053060 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.56298218 |
| 98 | MP0002796_impaired_skin_barrier | 0.55075446 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.54862927 |
| 100 | MP0000609_abnormal_liver_physiology | 0.53635901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.60036619 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.72395148 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.58047830 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.48869979 |
| 5 | Myositis (HP:0100614) | 4.45863078 |
| 6 | Orchitis (HP:0100796) | 4.26176014 |
| 7 | Optic neuritis (HP:0100653) | 4.01585503 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 4.01585503 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 3.92940051 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.78844007 |
| 11 | Meningitis (HP:0001287) | 3.74414698 |
| 12 | Stomatitis (HP:0010280) | 3.57968808 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.53039839 |
| 14 | Vasculitis (HP:0002633) | 3.47580479 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.45089038 |
| 16 | Cellulitis (HP:0100658) | 3.44938063 |
| 17 | Increased IgE level (HP:0003212) | 3.41355442 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.35176727 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.32930032 |
| 20 | Colitis (HP:0002583) | 3.28013311 |
| 21 | Spontaneous hematomas (HP:0007420) | 3.27494299 |
| 22 | Agammaglobulinemia (HP:0004432) | 3.26187350 |
| 23 | Gastrointestinal stroma tumor (HP:0100723) | 3.25756711 |
| 24 | Recurrent viral infections (HP:0004429) | 3.20076208 |
| 25 | Recurrent skin infections (HP:0001581) | 3.19725426 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19080969 |
| 27 | Obstructive lung disease (HP:0006536) | 3.19080969 |
| 28 | Inflammation of the large intestine (HP:0002037) | 3.09201963 |
| 29 | Pustule (HP:0200039) | 3.08167787 |
| 30 | Gastrointestinal inflammation (HP:0004386) | 3.06887699 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.02387931 |
| 32 | Gingivitis (HP:0000230) | 3.00783883 |
| 33 | Pulmonary infiltrates (HP:0002113) | 2.98094362 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 2.95723057 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.95723057 |
| 36 | Encephalitis (HP:0002383) | 2.89322973 |
| 37 | T lymphocytopenia (HP:0005403) | 2.87398265 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 2.81296997 |
| 39 | Keratoconjunctivitis (HP:0001096) | 2.74132644 |
| 40 | Hemoptysis (HP:0002105) | 2.70369452 |
| 41 | Abnormality of T cell number (HP:0011839) | 2.68503077 |
| 42 | Panhypogammaglobulinemia (HP:0003139) | 2.67188100 |
| 43 | Lymphopenia (HP:0001888) | 2.62795832 |
| 44 | Urticaria (HP:0001025) | 2.60686190 |
| 45 | Osteomyelitis (HP:0002754) | 2.59303837 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.56857762 |
| 47 | Recurrent bronchitis (HP:0002837) | 2.56717543 |
| 48 | Papilloma (HP:0012740) | 2.53035757 |
| 49 | Verrucae (HP:0200043) | 2.53035757 |
| 50 | Epistaxis (HP:0000421) | 2.49543242 |
| 51 | Emphysema (HP:0002097) | 2.48763568 |
| 52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.48489802 |
| 53 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.48489802 |
| 54 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.48489802 |
| 55 | Chest pain (HP:0100749) | 2.48414702 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.46687159 |
| 57 | Restrictive lung disease (HP:0002091) | 2.36122519 |
| 58 | Pulmonary embolism (HP:0002204) | 2.35337821 |
| 59 | Recurrent sinusitis (HP:0011108) | 2.35225164 |
| 60 | Malnutrition (HP:0004395) | 2.31245287 |
| 61 | Interstitial pulmonary disease (HP:0006530) | 2.28482878 |
| 62 | Gangrene (HP:0100758) | 2.27973181 |
| 63 | Gingival bleeding (HP:0000225) | 2.27523946 |
| 64 | Abnormality of T cells (HP:0002843) | 2.27212989 |
| 65 | Increased IgM level (HP:0003496) | 2.25269314 |
| 66 | Dysostosis multiplex (HP:0000943) | 2.24234664 |
| 67 | Arterial thrombosis (HP:0004420) | 2.22796993 |
| 68 | Sepsis (HP:0100806) | 2.22230052 |
| 69 | Hematochezia (HP:0002573) | 2.21696295 |
| 70 | Loss of speech (HP:0002371) | 2.20513486 |
| 71 | Skin ulcer (HP:0200042) | 2.16980166 |
| 72 | Leukocytosis (HP:0001974) | 2.16574806 |
| 73 | Premature loss of primary teeth (HP:0006323) | 2.16544700 |
| 74 | Hypergammaglobulinemia (HP:0010702) | 2.12757154 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.10493569 |
| 76 | Abnormality of the peritoneum (HP:0002585) | 2.09985216 |
| 77 | Peritonitis (HP:0002586) | 2.09610060 |
| 78 | Increased cerebral lipofuscin (HP:0011813) | 2.08817779 |
| 79 | Viral hepatitis (HP:0006562) | 2.08338617 |
| 80 | Purpura (HP:0000979) | 2.04594418 |
| 81 | Abnormality of the nasal mucosa (HP:0000433) | 2.04357735 |
| 82 | Granulocytopenia (HP:0001913) | 2.03892777 |
| 83 | Anorexia (HP:0002039) | 2.01561936 |
| 84 | IgM deficiency (HP:0002850) | 2.01301296 |
| 85 | Amyloidosis (HP:0011034) | 1.96803260 |
| 86 | Autoimmune hemolytic anemia (HP:0001890) | 1.94189206 |
| 87 | Recurrent pneumonia (HP:0006532) | 1.94052632 |
| 88 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93137809 |
| 89 | Glomerulonephritis (HP:0000099) | 1.92033403 |
| 90 | Increased serum ferritin (HP:0003281) | 1.91978930 |
| 91 | Chronic otitis media (HP:0000389) | 1.91975764 |
| 92 | Recurrent lower respiratory tract infections (HP:0002783) | 1.89793678 |
| 93 | Arthralgia (HP:0002829) | 1.89550184 |
| 94 | Nasal polyposis (HP:0100582) | 1.89494742 |
| 95 | Glomerulopathy (HP:0100820) | 1.89373936 |
| 96 | Chronic diarrhea (HP:0002028) | 1.88983631 |
| 97 | Abnormality of T cell physiology (HP:0011840) | 1.88760842 |
| 98 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.88590696 |
| 99 | Autoimmune thrombocytopenia (HP:0001973) | 1.88362535 |
| 100 | Episodic fever (HP:0001954) | 1.87404382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.31011240 |
| 2 | RIPK4 | 3.58581255 |
| 3 | ERN1 | 3.48028589 |
| 4 | PRPF4B | 2.94835643 |
| 5 | BLK | 2.76152525 |
| 6 | TYK2 | 2.63629229 |
| 7 | MAP3K14 | 2.37592204 |
| 8 | IRAK4 | 2.34815123 |
| 9 | CSK | 2.18715996 |
| 10 | MAP2K3 | 2.03789226 |
| 11 | MAP3K13 | 1.94673977 |
| 12 | ZAP70 | 1.91559955 |
| 13 | TXK | 1.91269894 |
| 14 | JAK3 | 1.85820817 |
| 15 | TRIB3 | 1.79532483 |
| 16 | FES | 1.76498692 |
| 17 | BTK | 1.74068672 |
| 18 | TBK1 | 1.71329523 |
| 19 | IKBKE | 1.70881996 |
| 20 | GRK6 | 1.65238747 |
| 21 | MAP3K3 | 1.65201064 |
| 22 | EPHB1 | 1.63319875 |
| 23 | IRAK3 | 1.60592895 |
| 24 | SIK3 | 1.60160219 |
| 25 | JAK1 | 1.52358677 |
| 26 | SYK | 1.50526453 |
| 27 | TAOK1 | 1.50007518 |
| 28 | SIK1 | 1.47948540 |
| 29 | MAP3K10 | 1.40529933 |
| 30 | CDC42BPA | 1.39754428 |
| 31 | TNK2 | 1.37387746 |
| 32 | CSF1R | 1.36827279 |
| 33 | FGFR4 | 1.36798017 |
| 34 | FGR | 1.35298799 |
| 35 | HCK | 1.34830939 |
| 36 | RIPK1 | 1.31719990 |
| 37 | TGFBR2 | 1.31467986 |
| 38 | MAP3K11 | 1.28518745 |
| 39 | IKBKB | 1.28183381 |
| 40 | SMG1 | 1.26588529 |
| 41 | MAP3K1 | 1.22625990 |
| 42 | TAOK2 | 1.18703876 |
| 43 | LYN | 1.15161657 |
| 44 | LCK | 1.07400425 |
| 45 | MARK2 | 1.06008148 |
| 46 | ITK | 1.03536738 |
| 47 | JAK2 | 0.99658697 |
| 48 | SIK2 | 0.99376350 |
| 49 | KIT | 0.99312424 |
| 50 | NME2 | 0.99015047 |
| 51 | STK10 | 0.96839960 |
| 52 | MATK | 0.95494724 |
| 53 | BMPR2 | 0.90209808 |
| 54 | PRKD2 | 0.88386788 |
| 55 | IRAK1 | 0.86718181 |
| 56 | FGFR3 | 0.86027614 |
| 57 | MARK3 | 0.85844738 |
| 58 | KSR2 | 0.78554728 |
| 59 | TEC | 0.78429779 |
| 60 | HIPK2 | 0.77522856 |
| 61 | TESK2 | 0.77473053 |
| 62 | PTK6 | 0.74971084 |
| 63 | CDK12 | 0.74496275 |
| 64 | MAP3K7 | 0.73075498 |
| 65 | PDK1 | 0.72809437 |
| 66 | PDPK1 | 0.69720413 |
| 67 | MAPK7 | 0.69401946 |
| 68 | IRAK2 | 0.68833217 |
| 69 | NLK | 0.68221228 |
| 70 | CHUK | 0.66312485 |
| 71 | GRK7 | 0.65265956 |
| 72 | MAPK12 | 0.65240485 |
| 73 | TAOK3 | 0.64587108 |
| 74 | MAP3K6 | 0.62677024 |
| 75 | LRRK2 | 0.59702827 |
| 76 | ICK | 0.58572877 |
| 77 | EPHA3 | 0.56981704 |
| 78 | CDK4 | 0.55838605 |
| 79 | FYN | 0.52461824 |
| 80 | YES1 | 0.51152724 |
| 81 | PRKCQ | 0.50976584 |
| 82 | TTN | 0.50875879 |
| 83 | MAPK11 | 0.47707840 |
| 84 | RPS6KC1 | 0.47198568 |
| 85 | RPS6KL1 | 0.47198568 |
| 86 | MOS | 0.44773882 |
| 87 | MELK | 0.44502770 |
| 88 | RET | 0.43343473 |
| 89 | PIM1 | 0.43253908 |
| 90 | MAP3K2 | 0.40944464 |
| 91 | MAPKAPK2 | 0.39990871 |
| 92 | BMX | 0.38052286 |
| 93 | MAPK4 | 0.37285113 |
| 94 | PDGFRB | 0.36847676 |
| 95 | MAP3K5 | 0.36710014 |
| 96 | RPS6KA6 | 0.35207410 |
| 97 | MAP3K8 | 0.35066724 |
| 98 | MAP2K2 | 0.35019287 |
| 99 | CDK6 | 0.33980588 |
| 100 | SGK3 | 0.33607006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.74463011 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 2.69755385 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.67781475 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.60633215 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.55354341 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.49087152 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.47373801 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.31107960 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.12483032 |
| 10 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.11134974 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.02340654 |
| 12 | Asthma_Homo sapiens_hsa05310 | 1.98069438 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94000877 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.86912646 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.86820023 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.80991619 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.79828136 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.73567616 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72514019 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.66292800 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.64740125 |
| 22 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64524069 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.63115180 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.62813252 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.62786930 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.60239953 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.57943202 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.56858493 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.56395762 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49938598 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.46534479 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41016278 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40552839 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.32602671 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32165924 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29722055 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.27116525 |
| 38 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26952242 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.18641964 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.17626540 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.16927068 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13326719 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11557542 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.11303405 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.06004055 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04230769 |
| 47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99865790 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98860505 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98329940 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 0.95722409 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94728916 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 0.94108731 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.92443920 |
| 54 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89591258 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.88949671 |
| 56 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88820894 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.86336187 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81842799 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.81554506 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81224284 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80473188 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80096112 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79953484 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.79250922 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76888440 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75061318 |
| 67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69275706 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66473610 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64884489 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64605897 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64065396 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60893013 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.59379093 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59317170 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.59307047 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.58514673 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56942216 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54890070 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54774020 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54068927 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51664179 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.51396812 |
| 83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50932690 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50125361 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.47571265 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47228667 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46065424 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44749873 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44230656 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43297289 |
| 91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39935734 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38909486 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37704717 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35524768 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34322507 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33946493 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33303107 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32955074 |
| 99 | Focal adhesion_Homo sapiens_hsa04510 | 0.32730200 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31367918 |

